PENN ELAN enters COLLPLANT BIOTECHNOLOGIES LTD with 7.50K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001213900-26-030191
7.50K
Baseline shares
100% direct
7.50K
Direct ownership
1 position
42K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Restricted Share Units
DirectShares owned7.50K
Total
7.50K direct7.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Restricted Share Units | 7.50K | Direct |
| Total | 7.50K | 7.50K direct |
Derivative Holdings3
Options to Purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
10K
Shares owned
N/A
Exercise price
4.02
Expiration
—
Exercise window
—
Options to Purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
8K
Shares owned
N/A
Exercise price
6.39
Expiration
—
Exercise window
—
Options to Purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
24K
Shares owned
N/A
Exercise price
6.39
Expiration
—
Exercise window
—
Total
Underlying
42K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 4.02 | — | — | 10K | N/A |
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 6.39 | — | — | 8K | N/A |
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 6.39 | — | — | 24K | N/A |
| Total | 42K | 0.00 | ||||